Prestige Consumer Healthcare Inc. (PBH): debt financing — Prestige Consumer Healthcare amends ABL facility: $41.5M commitment increase, maturity extended to 2028

Prestige Consumer Healthcare Inc.

Revolving credit commitments increased by $41.5M (exhibit shows $41.5M, not $25M cited in filing summary).
Maturity extended to five years from Dec 8, 2023 (Dec 8, 2028), subject to springing maturity.
Deutsche Bank NY Branch exited as lender; a new lender joined with assignments and reallocations.
Amendment provides increased flexibility on restricted payments, debt incurrence, and borrowing base.
Borrower paid amendment fees: 0.10% of outstanding commitments plus 0.15% of new money commitments.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Prestige Consumer Healthcare Inc. amended revolving credit of $25 million increase in the aggregate revolving commitments with Citibank, N.A., as administrative agent, L/C issuer and swing line lender maturing five years from the effective date of the Amendment.

Instrument: revolving credit
Principal: $25 million increase in the aggregate revolving commitments
Counterparty: Citibank, N.A., as administrative agent, L/C issuer and swing line lender
Maturity: five years from the effective date of the Amendment
Event: amendment

Exact text from the filing

The Amendment provides for (i) a $25 million increase in the aggregate revolving commitments of all lenders under the Credit Agreement, (ii) an extension of the maturity date of the Credit Agreement to the date that is five years from the effective date of the Amendment

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Prestige Consumer Healthcare Inc. amended Amendment No. 9 with Citibank, N.A., as administrative agent, L/C issuer and swing line lender (effective 2023-12-08).

Action: amendment
Agreement: credit facility
Counterparty: Citibank, N.A., as administrative agent, L/C issuer and swing line lender
Effective: 2023-12-08

Exact text from the filing

On December 8, 2023, Prestige Consumer Healthcare Inc. (the “ Company ”) and its wholly owned subsidiary, Prestige Brands, Inc. (the “ Borrower ”) entered into Amendment No. 9 (the “ Amendment ”) to the ABL Credit Agreement

View on SEC.gov

Browse all debt financings →

Prestige Consumer Healthcare Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-125696

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.